In the DSS-induced colitis model, HDAC inhibitor can increase the expression of the Foxp3 gene and improve the inhibitory function of regulatory T cells in mice with colitis, thus alleviating the inflammation phenotype (de Zoeten et al., 2010). The gene discussed is HDAC9; the disease is colitis.